查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386205

百日咳疫苗市場報告：2030 年趨勢、預測與競爭分析

Pertussis Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

百日咳疫苗趨勢與預測

預計到 2030 年，全球百日咳疫苗市場將達到約 91 億美元，2024 年至 2030 年複合年成長率為 5.6%。該市場的主要促進因素是人們對百日咳疫苗接種重要性的認知不斷提高、政府促進百日咳疫苗接種的支持措施以及新型百日咳疫苗的不斷開發。由於疫苗接種中心、醫院和診所市場的商機，全球百日咳疫苗市場的未來性看好。

百日咳疫苗市場洞察

Lucintel 預計 Dtap 將繼續佔很大的市場佔有率，因為它作為預防白喉、破傷風和百日咳的組合疫苗具有重要用途。

由於老年人口的增加和百日咳死亡人數的增加，預計北美在預測期內將經歷最高的成長。

市場規模/估計：以金額（B 美元）估計百日咳疫苗的市場規模。

趨勢和預測分析：各個區隔市場和地區的市場趨勢（2018-2023）和預測（2024-2030）。

區隔市場分析：依類型、最終用途和地區金額（十億美元）估計百日咳疫苗市場規模。

區域分析：北美、歐洲、亞太地區和世界其他地區百日咳疫苗市場的區域區隔。

成長機會：以百日咳疫苗類型、最終用途和地區進行成長機會分析。

策略分析：百日咳疫苗市場併購、新產品開發、競爭形勢等。

基於波特五力模型的產業競爭實力分析。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球百日咳疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球百日咳疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 全球百日咳疫苗市場（依類型）
    • 百白破疫苗
    • 百日咳疫苗
  • 全球百日咳疫苗市場（依最終用途）
    • 疫苗接種中心
    • 醫院
    • 診所
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球百日咳疫苗市場區域分佈
  • 北美百日咳疫苗市場
  • 歐洲百日咳疫苗市場
  • 亞太百日咳疫苗市場
  • 其他地區百日咳疫苗市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球百日咳疫苗市場成長機會（依類型）
    • 全球百日咳疫苗市場成長機會（依最終用途）
    • 全球百日咳疫苗市場成長機會（依地區）
  • 全球百日咳疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球百日咳疫苗市場產能
    • 全球百日咳疫苗市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • Protein Sciences
  • GlaxoSmithKline
  • Sanofi Pasteur
  • Seqirus
  • Merck Sharp & Dohme
  • Novartis
  • Astellas Pharma
簡介目錄

Pertussis Vaccine Trends and Forecast

The future of the global pertussis vaccine market looks promising with opportunities in the vaccination center, hospital, and clinic markets. The global pertussis vaccine market is expected to reach an estimated $9.1 billion by 2030 with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are growing awareness of the importance of pertussis vaccination, supportive government initiatives to promote pertussis vaccination, and continous development of new pertussis vaccines.

A more than 150-page report is developed to help in your business decisions.

Pertussis Vaccine by Segment

The study includes a forecast for the global pertussis vaccine by type, end use, and region.

Pertussis Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Dtap Vaccine
  • Tdap Vaccine

Pertussis Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Vaccination Centers
  • Hospitals
  • Clinics
  • Others

Pertussis Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Pertussis Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pertussis vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pertussis vaccine companies profiled in this report include-

  • Protein Sciences
  • Glaxosmithkline
  • Sanofi Pasteur
  • Seqirus
  • Merck Sharp & Dohme
  • Novartis
  • Astellas Pharma

Pertussis Vaccine Market Insights

Lucintel forecasts that Dtap will remain the larger segment due to its significant use as combinated vaccine that protects against diphtheria, tetanus, and pertussis.

North America is expected to witness highest growth over the forecast period due to increasing number of geriatric population and rising pertussis death cases in the region.

Features of the Global Pertussis Vaccine Market

Market Size Estimates: Pertussis vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pertussis vaccine market size by type, end use, and region in terms of value ($B).

Regional Analysis: Pertussis vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the pertussis vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pertussis vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the pertussis vaccine market size?

Answer: The global pertussis vaccine market is expected to reach an estimated $9.1 billion by 2030.

Q.2 What is the growth forecast for pertussis vaccine market?

Answer: The global pertussis vaccine market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the pertussis vaccine market?

Answer: The major drivers for this market are growing awareness of the importance of pertussis vaccination, supportive government initiatives to promote pertussis vaccination, and continous development of new pertussis vaccines.

Q4. What are the major segments for pertussis vaccine market?

Answer: The future of the pertussis vaccine market looks promising with opportunities in the vaccination center, hospital, and clinic markets.

Q5. Who are the key pertussis vaccine market companies?

Answer: Some of the key pertussis vaccine companies are as follows:

  • Protein Sciences
  • Glaxosmithkline
  • Sanofi Pasteur
  • Seqirus
  • Merck Sharp & Dohme
  • Novartis
  • Astellas Pharma

Q6. Which pertussis vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that Dtap will remain the larger segment due to its significant use as combinated vaccine that protects against diphtheria, tetanus, and pertussis.

Q7. In pertussis vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to increasing number of geriatric population and rising pertussis death cases in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the pertussis vaccine market by type (Dtap vaccine and Tdap vaccine), end use (vaccination centers, hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pertussis Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Pertussis Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Pertussis Vaccine Market by Type
    • 3.3.1: Dtap Vaccine
    • 3.3.2: Tdap Vaccine
  • 3.4: Global Pertussis Vaccine Market by End Use
    • 3.4.1: Vaccination Centers
    • 3.4.2: Hospitals
    • 3.4.3: clinics
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Pertussis Vaccine Market by Region
  • 4.2: North American Pertussis Vaccine Market
    • 4.2.2: North American Pertussis Vaccine Market by End Use: Vaccination Centers, Hospitals, clinics, and Others
  • 4.3: European Pertussis Vaccine Market
    • 4.3.1: European Pertussis Vaccine Market by Type: Dtap Vaccine and Tdap Vaccine
    • 4.3.2: European Pertussis Vaccine Market by End Use: Vaccination Centers, Hospitals, clinics, and Others
  • 4.4: APAC Pertussis Vaccine Market
    • 4.4.1: APAC Pertussis Vaccine Market by Type: Dtap Vaccine and Tdap Vaccine
    • 4.4.2: APAC Pertussis Vaccine Market by End Use: Vaccination Centers, Hospitals, clinics, and Others
  • 4.5: ROW Pertussis Vaccine Market
    • 4.5.1: ROW Pertussis Vaccine Market by Type: Dtap Vaccine and Tdap Vaccine
    • 4.5.2: ROW Pertussis Vaccine Market by End Use: Vaccination Centers, Hospitals, clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Pertussis Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Pertussis Vaccine Market by End Use
    • 6.1.3: Growth Opportunities for the Global Pertussis Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Pertussis Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Pertussis Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pertussis Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Protein Sciences
  • 7.2: GlaxoSmithKline
  • 7.3: Sanofi Pasteur
  • 7.4: Seqirus
  • 7.5: Merck Sharp & Dohme
  • 7.6: Novartis
  • 7.7: Astellas Pharma